Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

US Healthcare Ishares ETF (NY: IYH )

268.10 +3.37 (+1.27%)
Official Closing Price Updated: 8:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 34,917
Open 264.07
Bid (Size) 252.88 (2)
Ask (Size) 282.73 (2)
Prev. Close 264.73
Today's Range 263.61 - 268.30
52wk Range 247.38 - 301.63
Shares Outstanding 116,500
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks Flounder Despite Inflation Downtrend As Banking Crisis Emerges, But Outlook Remains Encouraging
Nothing goes in a straight line for long, and inflation is no different, i.e., the path is volatile, but disinflationary trends remain intact. 
Via Talk Markets
Got $10,000? Buy These 2 Market-Beating ETFs for the Long Haul
These exchange-traded funds have soundly beaten the S&P 500 over the past 10 years. 
Via The Motley Fool

Performance

YTD
-5.10%
-5.10%
1 Month
-0.55%
-0.55%
3 Month
-5.27%
-5.27%
6 Month
+5.93%
+5.93%
1 Year
-7.03%
-7.03%

More News

Read More
Uncertainties On Fed Policy, Geopolitics, And Earnings Cloud 2023 Outlook, But Trends Are Promising
Via Talk Markets
Worried About 2023? Here's a Safer Way to Invest in Stocks This Year
Via The Motley Fool
The 3 Best Sectors to Invest in for 2023
Via InvestorPlace
Health Care Exposure Ahead Of CPI Data, Progressive, Dollar General And Seagate Technology Feature On CNBC's 'Final Trades'
Via Benzinga
Investors Await Bullish Catalysts As Inflation, Interest Rates, And Money Supply Growth Show Signs Of Topping
Via Talk Markets
CNBC's Final Trades: Microsoft, US Dollar Index, iShares Healthcare ETF And This Cybersecurity Tech Major
Via Benzinga
Adobe Earnings Strangle Trade
Via Talk Markets
Why WHO Did Not Recommend Convalescent Plasma Therapy For COVID-19
Via Benzinga
Exposures COVID-19
New Drug Applications Pile Up With FDA As Pandemic Still Sore Spot For Delayed Inspections
Via Benzinga
Exposures Product Safety
Entering Q4 with mix of optimism and caution suggests hedged long positioning
Via Talk Markets
4 Defensive Sector ETFs to Protect Your Portfolio
Via Talk Markets
J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data
Via Talk Markets
Exposures COVID-19
5 ETF Areas for Investors to Consider Amid the September Slump
Via Talk Markets
Blowout earnings, low interest rates, and dovish Fed, but have stocks hit a peak?
Via Talk Markets
Topics Economy
Exposures Interest Rates
UK Rolls Out COVID-19 Antibody Tests For All: What You Need To Know
Via Benzinga
Exposures COVID-19
'Fast Money Halftime Report' Picks For August 4
Via Benzinga
Healthcare ETFs in Focus as Q2 Earnings Unfold
Via Talk Markets
Earnings momentum trumps overblown worries about inflation and valuations
Via Talk Markets
2 ETFs That Can Help Recession-Proof Your Portfolio
Via The Motley Fool
Topics Economy
Exposures Economy
Healthcare ETFs on Radar As Q1 Earnings Unfold
Via Talk Markets
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.